What the Blocked Insulin Price-cap Means for Diabetics
A number of senators who voted against the gap come from states with diabetes' highest mortality rates
The Senate passed a sweeping budget package Sunday intended to bring financial relief to Americans, but not before Republican senators voted to strip a proposal that would have capped the price of insulin at $35 per month for many patients.
A proposal that limits the monthly cost of insulin to $35 for Medicare patients was left untouched. But using a parliamentary rule, GOP lawmakers were able to jettison the part of the proposal that would apply to privately insured patients.
Seven Republicans joined Democrats in supporting the broader price cap, but that wasn't enough for passage. A number of Republican senators who voted for the proposal's removal come from states with some of the highest mortality rates for diabetes, according to data from the Centers for Disease Control and Prevention (CDC), including Arkansas, Oklahoma and Tennessee.
Please select this link to read the complete article from The Washington Post.